Clinical Trial Update: Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating allopurinol and trimetazidine as preventive strategies for acute kidney injury in patients undergoing PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Kidney Injury Following Percutaneous Coronary Intervention

Drugs mentioned

• Allopurinol (Allopurinol)
• Trimetazidine (trimetazidine)

Snippet

Sponsor: Beni-Suef University | Conditions: AKI - Acute Kidney Injury | Phase 4 | Status: UNKNOWN